ZA942911B - Therapeutic compounds - Google Patents
Therapeutic compoundsInfo
- Publication number
- ZA942911B ZA942911B ZA942911A ZA942911A ZA942911B ZA 942911 B ZA942911 B ZA 942911B ZA 942911 A ZA942911 A ZA 942911A ZA 942911 A ZA942911 A ZA 942911A ZA 942911 B ZA942911 B ZA 942911B
- Authority
- ZA
- South Africa
- Prior art keywords
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939308652A GB9308652D0 (en) | 1993-04-27 | 1993-04-27 | Anti-inflammatory compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA942911B true ZA942911B (en) | 1995-10-26 |
Family
ID=10734525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA942911A ZA942911B (en) | 1993-04-27 | 1994-04-26 | Therapeutic compounds |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0696271A1 (en) |
JP (1) | JPH08509487A (en) |
AU (1) | AU6574994A (en) |
GB (1) | GB9308652D0 (en) |
WO (1) | WO1994025430A1 (en) |
ZA (1) | ZA942911B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3322885B2 (en) * | 1995-02-02 | 2002-09-09 | 日研化学株式会社 | N-hydroxyurea derivative |
ATE301457T1 (en) * | 1995-06-12 | 2005-08-15 | Searle & Co | AGENT CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR |
WO2005061448A1 (en) * | 2003-12-24 | 2005-07-07 | Monash University | Compositions and methods for treating vascular conditions |
ES2569660T3 (en) | 2007-06-08 | 2016-05-12 | Mannkind Corporation | IRE-1alpha inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI89709C (en) * | 1985-03-16 | 1993-11-10 | Wellcome Found | ADJUSTMENT OF THERAPEUTIC MEASURES |
PL154186B1 (en) * | 1987-07-15 | 1991-07-31 | Wellcome Found | Method for manufacturing arylic derivatives of the hydroxamic acid |
JPH02270855A (en) * | 1989-02-03 | 1990-11-05 | Wellcome Found Ltd:The | Anti-inflammatory aryl compound |
JPH06256285A (en) * | 1990-12-11 | 1994-09-13 | Pfizer Pharmaceut Co Ltd | Hydroxamic acid derivative and its use |
US5169854A (en) * | 1992-02-26 | 1992-12-08 | Abbott Laboratories | N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity |
-
1993
- 1993-04-27 GB GB939308652A patent/GB9308652D0/en active Pending
-
1994
- 1994-04-26 EP EP94913699A patent/EP0696271A1/en not_active Ceased
- 1994-04-26 WO PCT/GB1994/000885 patent/WO1994025430A1/en not_active Application Discontinuation
- 1994-04-26 JP JP6524018A patent/JPH08509487A/en active Pending
- 1994-04-26 ZA ZA942911A patent/ZA942911B/en unknown
- 1994-04-26 AU AU65749/94A patent/AU6574994A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU6574994A (en) | 1994-11-21 |
GB9308652D0 (en) | 1993-06-09 |
EP0696271A1 (en) | 1996-02-14 |
JPH08509487A (en) | 1996-10-08 |
WO1994025430A1 (en) | 1994-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0714302A4 (en) | Therapeutic compounds | |
GB9421709D0 (en) | Therapeutic compounds | |
GB9300051D0 (en) | Therapeutic agents | |
ZA955644B (en) | Therapeutic compounds | |
GB9310199D0 (en) | Therapeutic compounds | |
GB9307013D0 (en) | Therapeutic combinations | |
AP9400637A0 (en) | Therapeutic c compounds | |
GB9305644D0 (en) | Therapeutic agents | |
ZA946217B (en) | Therapeutic combination | |
ZA942911B (en) | Therapeutic compounds | |
GB9316931D0 (en) | Therapeutic compounds | |
GB9316943D0 (en) | Therapeutic compounds | |
GB9306646D0 (en) | Therapeutic agetns | |
GB9308962D0 (en) | Therapeutic agetns | |
GB9222934D0 (en) | Therapeutic compounds | |
GB9226526D0 (en) | Therapeutic compounds | |
GB9323437D0 (en) | Therapy | |
GB9416629D0 (en) | Therapeutic compounds | |
GB9416632D0 (en) | Therapeutic compounds | |
SI0769017T1 (en) | Therapeutic compounds | |
GB9303243D0 (en) | Therapeutic agents | |
GB9304525D0 (en) | Therapeutic agents | |
GB9307278D0 (en) | Therapeutic agents | |
GB9306031D0 (en) | Therapeutic agents | |
GB9300062D0 (en) | Therapeutic agents |